GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Affluent Medical (XPAR:AFME) » Definitions » EV-to-EBIT

Affluent Medical (XPAR:AFME) EV-to-EBIT : -4.89 (As of May. 30, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Affluent Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Affluent Medical's Enterprise Value is €72.10 Mil. Affluent Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €-14.75 Mil. Therefore, Affluent Medical's EV-to-EBIT for today is -4.89.

The historical rank and industry rank for Affluent Medical's EV-to-EBIT or its related term are showing as below:

XPAR:AFME' s EV-to-EBIT Range Over the Past 10 Years
Min: -4.89   Med: 0   Max: 0
Current: -4.89

XPAR:AFME's EV-to-EBIT is ranked worse than
100% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 19.435 vs XPAR:AFME: -4.89

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Affluent Medical's Enterprise Value for the quarter that ended in Jun. 2024 was €67.71 Mil. Affluent Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €-14.75 Mil. Affluent Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -21.78%.


Affluent Medical EV-to-EBIT Historical Data

The historical data trend for Affluent Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affluent Medical EV-to-EBIT Chart

Affluent Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only - -9.12 -3.39 -4.63 -3.61

Affluent Medical Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.39 - -4.63 - -

Competitive Comparison of Affluent Medical's EV-to-EBIT

For the Medical Devices subindustry, Affluent Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Affluent Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Affluent Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Affluent Medical's EV-to-EBIT falls into.


;
;

Affluent Medical EV-to-EBIT Calculation

Affluent Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=72.095/-14.748
=-4.89

Affluent Medical's current Enterprise Value is €72.10 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Affluent Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €-14.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Affluent Medical  (XPAR:AFME) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Affluent Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2024 ) =EBIT / Enterprise Value (Q: Jun. 2024 )
=-14.748/67.70578
=-21.78 %

Affluent Medical's Enterprise Value for the quarter that ended in Jun. 2024 was €67.71 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Affluent Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €-14.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Affluent Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Affluent Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Affluent Medical Business Description

Traded in Other Exchanges
Address
320, Avenue Archimede, Les Pleiades III, Batiment B, Aix-en-Provence, FRA, 13100
Affluent Medical is a medical device company. The company is developing, next-generation minimally invasive medical devices for the treatment of severe pathologies in urology and structural heart. The product portfolio of the company includes Artus, Kalios, Epygon, and Kardiozis. It has a single operating segment that conducts research and development of medical devices with a view to its future marketing.

Affluent Medical Headlines

No Headlines